These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20183449)

  • 21. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets.
    Siddiqui O; Hung HM; O'Neill R
    J Biopharm Stat; 2009; 19(2):227-46. PubMed ID: 19212876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection models and pattern-mixture models for incomplete data with covariates.
    Michiels B; Molenberghs G; Lipsitz SR
    Biometrics; 1999 Sep; 55(3):978-83. PubMed ID: 11315038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of results from different imputation techniques for missing data from an anti-obesity drug trial.
    Jørgensen AW; Lundstrøm LH; Wetterslev J; Astrup A; Gøtzsche PC
    PLoS One; 2014; 9(11):e111964. PubMed ID: 25409438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of alternative strategies for analysis of longitudinal trials with dropouts.
    Liu G; Gould AL
    J Biopharm Stat; 2002 May; 12(2):207-26. PubMed ID: 12413241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How should we deal with missing data in clinical trials involving Alzheimer's disease patients?
    Coley N; Gardette V; Cantet C; Gillette-Guyonnet S; Nourhashemi F; Vellas B; Andrieu S
    Curr Alzheimer Res; 2011 Jun; 8(4):421-33. PubMed ID: 21244348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multiple-imputation-based approach to sensitivity analyses and effectiveness assessments in longitudinal clinical trials.
    Ayele BT; Lipkovich I; Molenberghs G; Mallinckrodt CH
    J Biopharm Stat; 2014; 24(2):211-28. PubMed ID: 24605966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Getting carried away: a note showing baseline observation carried forward (BOCF) results can be calculated from published complete-cases results.
    Kaiser KA; Affuso O; Beasley TM; Allison DB
    Int J Obes (Lond); 2012 Jun; 36(6):886-9. PubMed ID: 21407169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining, evaluating, and removing bias induced by linear imputation in longitudinal clinical trials with MNAR missing data.
    Helms RW; Reece LH; Helms RW; Helms MW
    J Biopharm Stat; 2011 Mar; 21(2):226-51. PubMed ID: 21390998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple correction to completer analyses and improvement on baseline observation carried forward.
    Petroff D
    Biometrics; 2017 Dec; 73(4):1366-1378. PubMed ID: 28199733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review finds variable use of the intention-to-treat principle in musculoskeletal randomized controlled trials with missing data.
    Joseph R; Sim J; Ogollah R; Lewis M
    J Clin Epidemiol; 2015 Jan; 68(1):15-24. PubMed ID: 25304501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of analytic method on interpretation of outcomes in longitudinal clinical trials.
    Prakash A; Risser RC; Mallinckrodt CH
    Int J Clin Pract; 2008 Aug; 62(8):1147-58. PubMed ID: 18564199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MMRM versus MI in dealing with missing data--a comparison based on 25 NDA data sets.
    Siddiqui O
    J Biopharm Stat; 2011 May; 21(3):423-36. PubMed ID: 21442517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addressing missing data in clinical trials.
    Fleming TR
    Ann Intern Med; 2011 Jan; 154(2):113-7. PubMed ID: 21242367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marginal analysis of incomplete longitudinal binary data: a cautionary note on LOCF imputation.
    Cook RJ; Zeng L; Yi GY
    Biometrics; 2004 Sep; 60(3):820-8. PubMed ID: 15339307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allowing for uncertainty due to missing and LOCF imputed outcomes in meta-analysis.
    Mavridis D; Salanti G; Furukawa TA; Cipriani A; Chaimani A; White IR
    Stat Med; 2019 Feb; 38(5):720-737. PubMed ID: 30347460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to use published complete case results from weight loss studies in a missing data sensitivity analysis.
    Cresswell L; Mander AP
    Obesity (Silver Spring); 2014 Apr; 22(4):996-1001. PubMed ID: 24124049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review of randomised controlled trials in rheumatoid arthritis: the reporting and handling of missing data in composite outcomes.
    Ibrahim F; Tom BD; Scott DL; Prevost AT
    Trials; 2016 Jun; 17(1):272. PubMed ID: 27255212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple imputation for model checking: completed-data plots with missing and latent data.
    Gelman A; Van Mechelen I; Verbeke G; Heitjan DF; Meulders M
    Biometrics; 2005 Mar; 61(1):74-85. PubMed ID: 15737080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A local influence sensitivity analysis for incomplete longitudinal depression data.
    Shen S; Beunckens C; Mallinckrodt C; Molenberghs G
    J Biopharm Stat; 2006 May; 16(3):365-84. PubMed ID: 16724491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accounting for uncertainty due to 'last observation carried forward' outcome imputation in a meta-analysis model.
    Dimitrakopoulou V; Efthimiou O; Leucht S; Salanti G
    Stat Med; 2015 Feb; 34(5):742-52. PubMed ID: 25492741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.